Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Age between 6 and 59 months~* Weight ≥ 5 Kg~* P. falciparum infections (density threshold at inclusion between 2,000 and 200,000/µl)~* Fever (≥ 37.5°C) or history of fever in the previous 24 hours~Exclusion criteria:~* severe or complicated malaria~* reported hypersensitivities of the studied drugs~* serious concomitant febrile illness

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 59 Months
- Healthy Volunteers: f

Study Arms:
- Artesunate and Amodiaquine (ASAQ) (Type: EXPERIMENTAL): children receiving fixed-dose combination of artesunate and amodiaquine
- Arthemeter and Lumefantrine (AL) (Type: ACTIVE_COMPARATOR): children receiving fixed-dose combination of arthemeter and lumefantrine

Based on this trial design, predict the completion outcome and termination type (if applicable).